Cargando…

Erratum to “Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease”

Detalles Bibliográficos
Autores principales:	Yang, Fuyuan, Zhou, Jianxiang, Su, Bo, Zhang, Qiong, Luo, Xuezhi, Wang, Fei, Huang, Jiangrong, Huang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392637/ https://www.ncbi.nlm.nih.gov/pubmed/35996404 http://dx.doi.org/10.1155/2022/9782896

Ejemplares similares

Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease
por: Yang, Fuyuan, et al.
Publicado: (2022)

Lingguizhugan Decoction Protects against High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease by Alleviating Oxidative Stress and Activating Cholesterol Secretion
por: Yang, Lili, et al.
Publicado: (2017)

The Effect of Bariatric Surgeries on Nonalcoholic Fatty Liver Disease: Erratum
Publicado: (2015)

Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis via gut microbiota
por: Liu, Meng-Ting, et al.
Publicado: (2019)

Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia: Erratum
Publicado: (2017)

Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”
por: Hirata, Takumi, et al.
Publicado: (2014)

Erratum: The p66shc-Mediated Regulation of Hepatocyte Senescence Influences Hepatic Steatosis in Nonalcoholic Fatty Liver Disease
por: Zhang, Jing, et al.
Publicado: (2020)

Erratum: Nonalcoholic fatty liver disease burden – Saudi Arabia and United Arab Emirates, 2017–2030
Publicado: (2018)

Visceral Adipose Tissue Area as an Independent Risk Factor for Elevated Liver Enzyme in Nonalcoholic Fatty Liver Disease: Erratum
Publicado: (2015)

Chinese Medicine Formula Lingguizhugan Decoction Improves Beta-Oxidation and Metabolism of Fatty Acid in High-Fat-Diet-Induced Rat Model of Fatty Liver Disease
por: Liu, Tao, et al.
Publicado: (2013)

Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites
por: Zhu, Mingzhe, et al.
Publicado: (2023)

Modified lingguizhugan decoction incorporated with dietary restriction and exercise ameliorates hyperglycemia, hyperlipidemia and hypertension in a rat model of the metabolic syndrome
por: Yao, Limei, et al.
Publicado: (2017)

Erratum to “Low‐molecular weight oligosaccharides from gum tragacanth (Astragalus gossypinus) ameliorate nonalcoholic fatty liver disease (NAFLD) in Wistar male rats”
Publicado: (2023)

PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis: Erratum
por: Jin, Kangpeng, et al.
Publicado: (2022)

Lingguizhugan decoction attenuates doxorubicin-induced heart failure in rats by improving TT-SR microstructural remodeling
por: Li, Xueping, et al.
Publicado: (2019)

Lingguizhugan Decoction Targets Intestinal Microbiota and Metabolites to Reduce Insulin Resistance in High-Fat Diet Rats
por: Ning, Ying, et al.
Publicado: (2022)

Lingguizhugan decoction improves non-alcoholic fatty liver disease by altering insulin resistance and lipid metabolism related genes: a whole trancriptome study by RNA-Seq
por: Zhu, Mingzhe, et al.
Publicado: (2017)

Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages
por: Cao, Lin, et al.
Publicado: (2022)

Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial
por: Xu, Jingjuan, et al.
Publicado: (2020)

Erratum to study on the mechanism of the Modified Ginseng-Schisandra Decoction (MGSD) in the treatment of recurrent respiratory tract infection (RRTI) based on network pharmacology
Publicado: (2021)

Erratum. A High-Fat Diet Attenuates AMPK α1 in Adipocytes to Induce Exosome Shedding and Nonalcoholic Fatty Liver Development In Vivo. Diabetes 2021;70:577–588
por: Yan, Chenghui, et al.
Publicado: (2021)

Protective effects of Lingguizhugan decoction on amyloid-beta peptide (25-35)-induced cell injury: Anti-inflammatory effects☆
por: Xi, Feifei, et al.
Publicado: (2012)

Xuefu Zhuyu decoction for nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis
por: Liu, Jiaxin, et al.
Publicado: (2021)

Effectiveness of Fuyuan Xingnao Decoction for patients with diabetes mellitus combined cerebral infarction: Erratum
Publicado: (2019)

Phytochemical Analysis Using UPLC-MS/MS Combined with Network Pharmacology Methods to Explore the Biomarkers for the Quality Control of Lingguizhugan Decoction
por: Li, Baolin, et al.
Publicado: (2021)

Erratum to clinical observation of the effect of modified Ginseng-Schisandra decoction (MGSD) on trace elements and immune function in children with spleen deficiency syndrome after recurrent respiratory tract infection (RRTI)
Publicado: (2021)

Xiaochaihu decoction for nonalcoholic fatty liver disease: A protocol for a systematic review and meta-analysis
por: Zhu, Wenyu, et al.
Publicado: (2021)

Efficacy of Duohuojisheng decoction monotherapy for the treatment of knee osteoarthritis: A protocol of a systematic review of randomized controlled trials: Erratum
Publicado: (2019)

Intervention of Shugan Xiaozhi Decoction on Nonalcoholic Fatty Liver Disease via Mediating Gut-Liver Axis
por: Yang, Huili, et al.
Publicado: (2022)

Erratum to: Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?
por: Yeung, Emily N. W., et al.
Publicado: (2016)

Erratum to: Assessment of Vitamin D status in a group of Egyptian children with non alcoholic fatty liver disease (multicenter study)
por: Mohamed, Amal Ahmed, et al.
Publicado: (2016)

Wendan decoction in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis
por: Zhang, Yufeng, et al.
Publicado: (2022)

Erratum to “Xiao-Xu-Ming Decoction Protects against Blood-Brain Barrier Disruption and Neurological Injury Induced by Cerebral Ischemia and Reperfusion in Rats”
por: Lan, Rui, et al.
Publicado: (2013)

Erratum to “Protective Effects of Ecklonia stolonifera Extract on Ethanol-Induced Fatty Liver in Rats” [Biomol.Ther. 24 (2016) 650–658]
por: Bang, Chae-Young, et al.
Publicado: (2017)

Erratum to ‘Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease’ (JHEP Reports 5 [2023] 100836)
por: Cheng, Yu-Ming, et al.
Publicado: (2023)

Jiedu Sangen Decoction Reverses Epithelial-to-mesenchymal Transition and Inhibits Invasion and Metastasis of Colon Cancer via AKT/GSK-3β Signaling Pathway: Erratum
por: Yuan, Li, et al.
Publicado: (2022)

Erratum for Fang and Casadevall, Research Funding: the Case for a Modified Lottery
por: Fang, Ferric C., et al.
Publicado: (2016)

Thromboelastometry: Relation to the severity of liver cirrhosis in patients considered for liver transplantation: Erratum
Publicado: (2017)

Erratum for Juvenile Hepatocellular Carcinoma in a Healthy Liver
por: Onishi, Sachiyo, et al.
Publicado: (2022)

Intervening TNF-α via PPARγ with Gegenqinlian Decoction in Experimental Nonalcoholic Fatty Liver Disease
por: Wang, Yun-liang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rlqmqph08fp93tkkc28fpvreqn